Dr. Reddy’s Bid To Revive Growth In Its Largest Market At Risk
A box of Indivior’s Suboxone medication on a pharmacy shelf. (Photographer: George Frey/Bloomberg)

Dr. Reddy’s Bid To Revive Growth In Its Largest Market At Risk

The uncertainty over the U.S. government shutdown may affect Dr. Reddy’s Laboratories Ltd.’s plans to gain first-mover advantage in the country’s market for generics of the opioid treatment drug Su...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.